Icecure Medical Ltd. current report, Q3 FY2022

Business Context and Reporting Period

Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: July 11, 2022
Context: The registrant filed this report to make available an updated corporate presentation on its website, attached as Exhibit 99.1. The filing explicitly states that the presentation does not constitute a prospectus or an offer to sell securities.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 6-K serves solely as a conduit for the attached corporate presentation and contains no embedded financial tables or specific numerical data.

Material Changes

No material changes regarding financial performance or operations are detailed in the text of this filing. The only reported activity is the release of the updated corporate presentation.

Guidance, Outlook, and Risks

Management Commentary: The filing includes a standard disclaimer that the attached presentation is not an offering document and should not be relied upon for any action or contract regarding the company's securities.
Risks and Contingencies: No specific risks or contingencies are enumerated in the body of this filing text.

Investor Verification Checklist

  • Review the attached Exhibit 99.1 (Corporate Presentation dated July 11, 2022) for actual financial data and strategic updates.
  • Verify the company's latest audited financial statements in its most recent Form 20-F, as this 6-K does not contain them.
  • Confirm the status of the company's clinical trials and regulatory approvals, which are typically detailed in the corporate presentation rather than the 6-K cover letter.